Skip to content

Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer: A Randomized Controlled Trial

Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002152
Enrollment
Unknown
Registered
2025-11-08
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative urinary retention

Interventions

EA Group (Treatment Group):EA Intervention
Sham EA Group (Control Group):Sham EA Intervention

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Cervical cancer patients aged 18-70 years with an expected survival period of = 6 months after radical surgery; (2) It meets the diagnostic criteria for postoperative urinary retention of cervical cancer, and the duration of the indwelling catheter is more than 14 days, but less than 6 months. (3) There was no serious urinary system disease in the past, and there was no urinary retention before the operation; (4) No serious mental illness, capable of daily living, able to cooperate in completing all treatments and examinations; (5) No serious systemic diseases such as heart, liver, brain, kidney, etc. (6) Karnofsky functional status score (KPS) = 70 points; (7) Voluntarily participate and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: (1) Obstructive urinary retention, such as urinary system diseases, such as urethral stricture or stones; (2) Merge other serious systemic diseases, advanced cachexia. (3) Those who are participating in other acupuncture and moxibustion or drug clinical trials; (4) Physical or mental disorders with cognitive impairment; (5) Severe skin damage, infection, ulceration, etc., at the treatment site; (6) Patients who are intolerant to electrical stimulation therapy, such as those with pacemakers installed. (7) Those who do not agree to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
The proportion of participants who removed the urinary catheter;

Secondary

MeasureTime frame
Residual urine volume of bladder;Patient Quality of Life Evaluation Scale(EQRTC QLQ-C30);The proportion of participants who have a urinary tract infection;

Countries

China

Contacts

Public ContactChao Lu

Zhejiang Cancer Hospital

luchao@zjcc.org.cn15869128904

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026